Skip to main content
. 2014 Sep 30;1:2. doi: 10.1186/2053-6844-1-2

Figure 3.

Figure 3

Growth inhibition assay. Dasatinib showed minimal to modest activity against leiomyosarcoma cell lines. Maximal growth inhibitory effect for SK-UT-1 and SK-UT-1B was 42.8% and 55% respectively.